Zanzalintinib
ZANACC
Exelixis · Phase 2 · Not yet recruiting · Enrollment 51
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
Zanzalintinib
Exelixis · Phase 2 · Not yet recruiting · Enrollment 51
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.